In addition to expression on tumour cells, higher levels of LILRB1 have been demonstrated on the peripheral blood of non-small cell lung cancer (NSCLC), renal, head and neck, oesophagus and colon cancer patients than healthy individuals (6). Here, LILRB1 is linked to neoplasm.